Back to moneycontrol.com

You are hereMoneycontrol MessageboardStocksAjanta Pharma

SENSEX   | NIFTY  
Ajanta Pharma 1113 opinions
BSE 406.50 -7.70 (-1.86%) | NSE 409.00 -4.30 (-1.04%) Detailed View

I agree to the M3 code of conduct
My Space
Home
Messages
Ajanta Pharma
FAQ's Code of conduct
Latest Messages
Platinum Member
17 Followers
http://t.in.com/6jxT , As per our Technical Analysis AJANTPHARM has a score of 68.33 out of 100 which is good and Bullish. Check out link for further relative strength analysis against its peers. 
6.54 PM Feb 17th
Platinum Member
65 Followers

Price when posted : BSE: Rs 406.50 ( -1.86 % ), NSE: Rs. 409.00 ( -1.04 % )

Ajanta Pharma made a high of 423 as aginst the given target of 421.50. Hope u have booked the profits in time.     2 replies
In reply to : pilatos message
4.29 PM Feb 17th
Platinum Member
65 Followers

Price when posted : BSE: Rs 414.20 ( 0.47 % ), NSE: Rs. 413.30 ( 0.17 % )

Intra day recommendations for the RISK TAKING Day Traders for Feb 16, 2012. Today’s TOP Buying Ideas. 1. Buy Ajanta Pharma @413.3; Target 421.50; S/L 409.20; 2. Buy Balkrishna Industrie@242.5; Target 247.30; S/L 2410.10; 3. Buy BPL @2... See more    2 replies
7.34 AM Feb 17th
Platinum Member
7 Followers
http://t.in.com/6jxT , As per our Technical Analysis AJANTPHARM has a score of 70.0 out of 100 which is good and Bullish. Check out link for further relative strength analysis against its peers. 
6.44 PM Feb 16th
Platinum Member
94363 Followers

Price when posted : [Ajanta Pharma - BSE:Rs. 414.20 NSE:Rs. 413.30 ]

Yogesh Mannalal Agrawal has submitted the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 to BSE: 
http://t.in.com/5kR8
5.38 PM Feb 16th
To follow up on what's new on your favourite topics follow the topics!

Follow the topics

Following a topic lets you view messages on those topics quickly. When you follow any topic, messages from those topics will appear on your Topics I am tracking section. You can also quickly access those topics from My Space section of your profile.

Platinum Member
29 Followers
On a bad day when Nifty is under pressure AJANTPHARM hit a new 52 week high Source is http://t.in.com/ceWj Let us see if it can hold and contnue the good run. 
1.33 PM Feb 16th
Platinum Member
3416 Followers

Price when posted : BSE:Rs. 414.10 NSE:Rs. 415.05

Ajanta Pharma has touched a 52-week high of Rs 424.00. At 11:13 hrs, the share was quoting at Rs 414.10, up Rs 1.85, or 0.45%. See more 
11.15 AM Feb 16th
Platinum Member
65 Followers

Price when posted : BSE: Rs 415.00 ( 0.67 % ), NSE: Rs. 415.30 ( 0.65 % )

Ajanta Pharma already made a high of 418.95 as against the target given 418 in the morning. Enjoy the trade pl.     2 replies
In reply to : pilatos message
9.43 AM Feb 16th
Platinum Member
65 Followers

Price when posted : BSE: Rs 412.25 ( 2.18 % ), NSE: Rs. 412.60 ( 1.94 % )

Intra day recommendations for the RISK TAKING Day Traders for Feb 16, 2012. Today’s TOP 10 Buying Ideas. 1. Buy Ajanta Pharma@412.60; Target 418.00; S/L 409.00; 2. Buy City Union Bk@49.65; Target 51.00; S/L 49.00; 3. Buy HOEC@133.65;... See more    2 replies
7.32 AM Feb 16th
Platinum Member
11 Followers
As per Money Flow Index AJANTPHARM is showing overbought levels. Soome correction may be on the cards. Check out the details http://t.in.com/3hnN . 
7.53 PM Feb 15th
AJANTA PHARMA NETWORK
atimorap
Platinum Member
stockfindtrade
Platinum Member
pilatos
Platinum Member
more
 
rajan.jayanthi
New Member
nooruddin786
New Member
jgshetye
New Member
more
Pharmaceuticals stocks
744 messages Platinum Member

122
KotakInvestment
Platinum Member

11788
Santosh Nair
Platinum Member

4368
marketman
Platinum Member

4359
Indira Vergis
Platinum Member

2908
chief_kamani
Platinum Member

2596
see all
Expert Chartist
Platinum Member

4942
Market Statistician
Platinum Member

3416
Shishir Asthana
Platinum Member

1301
Indira Vergis
Platinum Member

2908
Santosh Nair
Platinum Member

4368
more
BCCI agrees to Sahara's terms. Has BCCI been made to eat humble pie?
Yes
No
5 comments
view results

Explore Messageboard

Site Map  |  About Us  |  Contact Us  |  Advertise  |  Bookmark  |  Disclaimer  |  Privacy Statement  |  Terms of Use  |  Careers

Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.